Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer

Related articles

1. Efficacy of a New Selective Indole-based Histone Deacetylase 10 Inhibitor in Targeted Anticancer Therapy

   This article has 9 authors:

   1. Amer H. Tarawneh
   2. Salah A. Al-Trawneh
   3. Talha Z. Yesiloglu
   4. Matthes Zessin
   5. Dina Robaa
   6. Cyril Barinka
   7. Mike Schutkowski
   8. Wolfgang Sippl
   9. Samir A. Ross

2. Role of the NuRD complex and altered proteostasis in cancer cell quiescence

   This article has 14 authors:

   1. Qi Jiang
   2. Michelle Ertel
   3. Austin Arrigo
   4. Sara Sannino
   5. Jennifer L. Goeckeler-Fried
   6. April Sagan
   7. Betsy Ann Varghese
   8. Daniel D. Brown
   9. Wayne Stallaert
   10. Adrian Lee
   11. Amanda M. Clark
   12. Jeffrey L. Brodsky
   13. Hatice U. Osmanbeyoglu
   14. Ronald J. Buckanovich

3. Novel antibody cocktail therapy targeting extracellular tumor-specific mutations to treat triple-negative breast cancer

   This article has 10 authors:

   1. Stephanie C. Pero
   2. Girja S. Shukla
   3. Yujing Sun
   4. Ramiro Barrantes-Reynolds
   5. Colin J. Hartman
   6. Margaret E. Ackerman
   7. Linda Mei
   8. Fan Zhang
   9. Matthew R. Fournier
   10. David N. Krag